Results for the Third Quarter 2017

Sales ended at MNOK 75.7 for the quarter (MNOK 67.9), an 11.4 % growth.
Sales as of September increased by 9.3 % and ended at MOK 219.2 (MNOK 200.6)

Currency neutral growth of own products is 12.5%. Flow probe sales negatively impacted with MNOK 2.2, however, production of flow probe capacity is improving and backorder is reduced from 500 to 250 probes. Another strong quarter for the USA with currency neutral sales up 17.8 %. Read the full report below.

Financial Report Third quarter 2017

Medistim ASA Q3 2017 Presentation